Decentrialz logo
  • HIPAA Compliant
  • ISO 27001 Certified
Find Trials
About UsContact
Become a Volunteer+1 877 705 1914

Status:

RECRUITING

Peripheral Serotonin and Albinism

Lead Sponsor:

Assistance Publique - Hôpitaux de Paris

Collaborating Sponsors:

URC-CIC Paris Descartes Necker Cochin

Conditions:

Oculocutaneous Albinism

Eligibility:

All Genders

2-17 years

Brief Summary

Serotonin (5-HT or 5-hydroxytryptamine) is a monoamine primarily known for its role as a neurotransmitter in the central nervous system (CNS). However, the functions of serotonin go beyond its role in...

Detailed Description

Serotonin (5-HT or 5-hydroxytryptamine) is a monoamine primarily known for its role as a neurotransmitter in the central nervous system (CNS). However, the functions of serotonin go beyond its role in...

Eligibility Criteria

Inclusion

  • Patients:
  • Patients with albinism aged 2 to 17 years
  • Followed in the MAGEC-Necker reference center (reference center for rare diseases of the skin and mucous membranes of genetic origin), during the inclusion period
  • Information of parental authority holders of patients and patients of understanding age, and collection of consent from parental authority holders and patients.
  • Controls:
  • Patients aged 2 to 17 years old
  • Having consulted in Necker hospital during the inclusion period in the emergency and surgical services and whose care required a blood test analyzed in the hematology laboratory of the Necker hospital.
  • Normal complete blood count (CBC)
  • Normal C-reactive protein test (CRP)
  • Absence of opposition from parental authority holders within one month of after sending the study information note.

Exclusion

  • Patients:
  • \- Inability to have a blood test
  • Controls:
  • Abnormal blood count
  • Elevation of CRP above laboratory standard

Key Trial Info

Start Date :

February 6 2024

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

February 1 2026

Estimated Enrollment :

160 Patients enrolled

Trial Details

Trial ID

NCT06138509

Start Date

February 6 2024

End Date

February 1 2026

Last Update

September 12 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Hôpital Necker-Enfants Malades

Paris, France, 75015